Delivery Order SPE2DB25D2204-SPE2DB25FTGWU
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,089.66 to AmerisourceBergen Drug Corp for Lisdexamfetamine 40 mg capsules (100-count units). The contract is classified as a firm fixed-price delivery order with an ultimate completion date of August 18, 2025. This award was made through open competition with no set-aside designation. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $1,968.50 to AmerisourceBergen Drug Corp for the supply of Lisdexamfetamine 40 mg capsules (100-count units) on August 4, 2025, with an ultimate completion date of August 5, 2025. This firm fixed-price delivery order, with no set-aside designation, represents a competitively awarded transaction under AmerisourceBergen's existing contract vehicle with DLA. The pharmaceutical product will be performed and delivered from the...
- The Defense Logistics Agency has awarded a delivery order valued at $1,610.40 to AmerisourceBergen Drug Corp for the supply of Lisdexamfetamine 30 mg capsules (100-count units). This competitively awarded, firm fixed-price contract was executed on August 5, 2025, with an ultimate completion date of August 6, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Lisdexamfetamine 40 mg capsules (100-count units) valued at $5,911.41. This is a firm fixed-price delivery order with an ultimate completion date of August 19, 2025, and represents a non-set-aside competitive award. The order will be fulfilled from AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania, where the company maintains...
- The Defense Logistics Agency awarded a $1,706.90 firm fixed price delivery order to AmerisourceBergen Drug Corp for Lisdexamfetamine 10 mg capsules (100 count) on August 1, 2025, with an ultimate completion date of August 4, 2025. This non-set-aside contract was performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen Drug Corp's broader pharmaceutical supply relationship with the DLA. This award is issued...
- The Defense Logistics Agency awarded a delivery order valued at $8,166.54 to AmerisourceBergen Drug Corp for the supply of Lisdexamfetamine 20 mg capsules (100 count). This firm fixed-price delivery order, awarded on September 9, 2025, with an ultimate completion date of September 10, 2025, was competitively awarded without set-aside designation. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Lisdexamfetamine 40 mg capsules (100-count) valued at $2,057.66. The contract, which closed on August 28, 2025, represents a firm fixed-price delivery order with no set-aside designation. Performance will be fulfilled from the contractor's Conshohocken, Pennsylvania location, where AmerisourceBergen maintains its corporate office. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,401.40 to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Lisdexamfetamine 30 mg capsules (100 count). This is a firm fixed-price, competitively awarded delivery order with no set-aside designation and an ultimate completion date of July 29, 2025. The contract is being fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $1,760.99 to AmerisourceBergen Drug Corp for the supply of Lisdexamfetamine 50 mg capsules (90-count). The contract was awarded on July 21, 2025, with an ultimate completion date of July 22, 2025, and utilizes firm fixed pricing with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs across military and...
- The Defense Logistics Agency awarded a $9,594.39 delivery order to AmerisourceBergen Drug Corp for Lisdexamfetamine 40 mg capsules (100-count units) on August 8, 2025, with an ultimate completion date of August 11, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- SPE2DB25D2204Indefinite Delivery Contract
- SPE2DB25D2204-SPE2DB25FTGWUDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $4,605.78 to AmerisourceBergen Drug Corp for the supply of Lisdexamfetamine 40 mg capsules (100-count units). This is a firm fixed price, competitively awarded contract with no set-aside designation. The award was executed on August 18, 2025, with an ultimate completion date of August 19, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, performed the contract from its corporate office location. This delivery order is issued under AmerisourceBergen Drug Corp's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.999 billion comprehensive pharmaceutical support vehicle running through December 2026. The IDC serves as a global pharmaceutical supply vehicle for military healthcare programs, enabling the company to deliver a wide range of pharmaceutical products and medical supplies to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. AmerisourceBergen Drug Corp's federal contract portfolio demonstrates its established capability to fulfill diverse pharmaceutical procurement requirements through open competition, with contract values ranging from minimal amounts to substantial orders exceeding $45,000.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.6k | 8/18/25 |